scispace - formally typeset
P

Patrick Dufour

Researcher at University of Strasbourg

Publications -  107
Citations -  2874

Patrick Dufour is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Cancer & Chemotherapy. The author has an hindex of 28, co-authored 102 publications receiving 2728 citations.

Papers
More filters
Journal ArticleDOI

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

TL;DR: The present study suggests that SI resulted in a poorer liver functional reserve and in a higher complication rate after major hepatectomy, and female patients who received 6 cycles or more of OBC, or presenting with abnormal preoperative aspartate aminotransferase and ICG-R15 values should be carefully selected before deciding to undertake a major hepATEctomy.
Journal ArticleDOI

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

TL;DR: Galactomannan ELISA seems less sensitive than previously described, and sensitivity can be further reduced by the presence of anti-Aspergillus antibodies.
Journal ArticleDOI

Frequent factor II G20210A mutation in idiopathic portal vein thrombosis

TL;DR: The frequency of factor II G20210A mutation is frequent in patients with idiopathic portal vein thrombosis and should be assessed under this circumstance and was assessed in this study.
Journal ArticleDOI

Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.

TL;DR: In this article, the authors studied whether danazol, an attenuated androgen, is useful in the management of refractory chronic idiopathic thrombocytopenic purpura.
Journal ArticleDOI

Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience With 118 Patients

TL;DR: In a specialized setting, P-AR for locally advanced pancreatic adenocarcinoma can be performed safely with limited mortality and morbidity and negative resection margin and the absence of associated venous invasion might predict favorable long-term outcomes.